Cargando…

Human amniotic fluid as a source of stem cells

Human amniotic fluid collected during amniocentesis contains a heterogeneous population of differentiated and undifferentiated cells. Properties and number of these cells vary depending on the gestational age and the presence of potential fetal pathologies. The aim of this study was to analyze the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Walentowicz, Pawel, Sadlecki, Pawel, Walentowicz-Sadlecka, Malgorzata, Bajek, Anna, Grabiec, Marek, Drewa, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982042/
https://www.ncbi.nlm.nih.gov/pubmed/35434378
http://dx.doi.org/10.1515/med-2022-0468
_version_ 1784681725060710400
author Walentowicz, Pawel
Sadlecki, Pawel
Walentowicz-Sadlecka, Malgorzata
Bajek, Anna
Grabiec, Marek
Drewa, Tomasz
author_facet Walentowicz, Pawel
Sadlecki, Pawel
Walentowicz-Sadlecka, Malgorzata
Bajek, Anna
Grabiec, Marek
Drewa, Tomasz
author_sort Walentowicz, Pawel
collection PubMed
description Human amniotic fluid collected during amniocentesis contains a heterogeneous population of differentiated and undifferentiated cells. Properties and number of these cells vary depending on the gestational age and the presence of potential fetal pathologies. The aim of this study was to analyze the effects of maternal, fetal, and environmental factors on the success rates of amniotic fluid stem cell cultures, the number of human amniotic fluid stem cells (hAFSC), their growth rates in primary cultures, and the number of cell passages. The study included 355 patients qualified for genetic amniocentesis at the Prenatal Genetic Unit, Department of Obstetrics, Gynecology and Oncologic Gynecology, Nicolaus Copernicus University Medical College in Bydgoszcz in 2011–2017. The mean age of the study participants was 34 ± 6.2 years, and mean gravidity amounted to 2.48 ± 1.4. Amniotic fluid sample volume turned out to be a highly significant (p < 0.01) predictor of culture success, and the relationship was particularly evident in women older than 40 years. Another highly significant predictor of culture success was the presence of two cell populations in the sample (p < 0.01). The likelihood of culture success correlated significantly (p < 0.05) with the season of the year at the time of amniocentesis. The number of cell passages differed significantly depending on the maternal age (p < 0.01). The number of passages also showed a highly significant relationship with the season of the year the sample was obtained (p < 0.01). Younger maternal age was identified as a determinant of high passage number (≥3), and another highly significant determinant of high passage number was the presence of two cell populations in the amniotic fluid sample (p < 0.01). Percentage of successfully established hAFSC cultures and the number of passages depended on amniotic fluid volume, the presence of two cell populations within the sample, and the season of the year. Individual characteristics of the donors, such as age and gravidity, did not exert a significant effect on the number of isolated hAFSCs and the rate of their growth. Patients’ place of residence, fetal karyotype, transportation time, and purity of the samples did not affect the success rates for primary cultures and the number of passages.
format Online
Article
Text
id pubmed-8982042
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-89820422022-04-15 Human amniotic fluid as a source of stem cells Walentowicz, Pawel Sadlecki, Pawel Walentowicz-Sadlecka, Malgorzata Bajek, Anna Grabiec, Marek Drewa, Tomasz Open Med (Wars) Research Article Human amniotic fluid collected during amniocentesis contains a heterogeneous population of differentiated and undifferentiated cells. Properties and number of these cells vary depending on the gestational age and the presence of potential fetal pathologies. The aim of this study was to analyze the effects of maternal, fetal, and environmental factors on the success rates of amniotic fluid stem cell cultures, the number of human amniotic fluid stem cells (hAFSC), their growth rates in primary cultures, and the number of cell passages. The study included 355 patients qualified for genetic amniocentesis at the Prenatal Genetic Unit, Department of Obstetrics, Gynecology and Oncologic Gynecology, Nicolaus Copernicus University Medical College in Bydgoszcz in 2011–2017. The mean age of the study participants was 34 ± 6.2 years, and mean gravidity amounted to 2.48 ± 1.4. Amniotic fluid sample volume turned out to be a highly significant (p < 0.01) predictor of culture success, and the relationship was particularly evident in women older than 40 years. Another highly significant predictor of culture success was the presence of two cell populations in the sample (p < 0.01). The likelihood of culture success correlated significantly (p < 0.05) with the season of the year at the time of amniocentesis. The number of cell passages differed significantly depending on the maternal age (p < 0.01). The number of passages also showed a highly significant relationship with the season of the year the sample was obtained (p < 0.01). Younger maternal age was identified as a determinant of high passage number (≥3), and another highly significant determinant of high passage number was the presence of two cell populations in the amniotic fluid sample (p < 0.01). Percentage of successfully established hAFSC cultures and the number of passages depended on amniotic fluid volume, the presence of two cell populations within the sample, and the season of the year. Individual characteristics of the donors, such as age and gravidity, did not exert a significant effect on the number of isolated hAFSCs and the rate of their growth. Patients’ place of residence, fetal karyotype, transportation time, and purity of the samples did not affect the success rates for primary cultures and the number of passages. De Gruyter 2022-04-04 /pmc/articles/PMC8982042/ /pubmed/35434378 http://dx.doi.org/10.1515/med-2022-0468 Text en © 2022 Pawel Walentowicz et al., published by De Gruyter https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License.
spellingShingle Research Article
Walentowicz, Pawel
Sadlecki, Pawel
Walentowicz-Sadlecka, Malgorzata
Bajek, Anna
Grabiec, Marek
Drewa, Tomasz
Human amniotic fluid as a source of stem cells
title Human amniotic fluid as a source of stem cells
title_full Human amniotic fluid as a source of stem cells
title_fullStr Human amniotic fluid as a source of stem cells
title_full_unstemmed Human amniotic fluid as a source of stem cells
title_short Human amniotic fluid as a source of stem cells
title_sort human amniotic fluid as a source of stem cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982042/
https://www.ncbi.nlm.nih.gov/pubmed/35434378
http://dx.doi.org/10.1515/med-2022-0468
work_keys_str_mv AT walentowiczpawel humanamnioticfluidasasourceofstemcells
AT sadleckipawel humanamnioticfluidasasourceofstemcells
AT walentowiczsadleckamalgorzata humanamnioticfluidasasourceofstemcells
AT bajekanna humanamnioticfluidasasourceofstemcells
AT grabiecmarek humanamnioticfluidasasourceofstemcells
AT drewatomasz humanamnioticfluidasasourceofstemcells